Literature DB >> 17322527

Combining substrate dynamics, binding statistics, and energy barriers to rationalize regioselective hydroxylation of octane and lauric acid by CYP102A1 and mutants.

K Anton Feenstra1, Eugene B Starikov, Vlada B Urlacher, Jan N M Commandeur, Nico P E Vermeulen.   

Abstract

Hydroxylations of octane and lauric acid by Cytochrome P450-BM3 (CYP102A1) wild-type and three active site mutants--F87A, L188Q/A74G, and F87V/L188Q/A74G--were rationalized using a combination of substrate orientation from docking, substrate binding statistics from molecular dynamics simulations, and barrier energies for hydrogen atom abstraction from quantum mechanical calculations. Wild-type BM3 typically hydroxylates medium- to long-chain fatty acids on subterminal (omega-1, omega-2, omega-3) but not the terminal (omega) positions. The known carboxylic anchoring site Y51/R47 for lauric acid, and hydrophobic interactions and steric exclusion, mainly by F87, for octane as well as lauric acid, play a role in the binding modes of the substrates. Electrostatic interactions between the protein and the substrate strongly modulate the substrate's regiodependent activation barriers. A combination of the binding statistics and the activation barriers of hydrogen-atom abstraction in the substrates is proposed to determine the product formation. Trends observed in experimental product formation for octane and lauric acid by wild-type BM3 and the three active site mutants were qualitatively explained. It is concluded that the combination of substrate binding statistics and hydrogen-atom abstraction barrier energies is a valuable tool to rationalize substrate binding and product formation and constitutes an important step toward prediction of product ratios.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17322527      PMCID: PMC2203314          DOI: 10.1110/ps.062224407

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  45 in total

1.  Computer-assisted design of selective imidazole inhibitors for cytochrome p450 enzymes.

Authors:  Andreas Verras; Irwin D Kuntz; Paul R Ortiz de Montellano
Journal:  J Med Chem       Date:  2004-07-01       Impact factor: 7.446

2.  Quantum mechanical/molecular mechanical investigation of the mechanism of C-H hydroxylation of camphor by cytochrome P450cam: theory supports a two-state rebound mechanism.

Authors:  Jan C Schöneboom; Shimrit Cohen; Hai Lin; Sason Shaik; Walter Thiel
Journal:  J Am Chem Soc       Date:  2004-03-31       Impact factor: 15.419

3.  A single mutation in cytochrome P450 BM3 changes substrate orientation in a catalytic intermediate and the regiospecificity of hydroxylation.

Authors:  C F Oliver; S Modi; M J Sutcliffe; W U Primrose; L Y Lian; G C Roberts
Journal:  Biochemistry       Date:  1997-02-18       Impact factor: 3.162

4.  Substrate modulation of the properties and reactivity of the oxy-ferrous and hydroperoxo-ferric intermediates of cytochrome P450cam as shown by cryoreduction-EPR/ENDOR spectroscopy.

Authors:  Roman Davydov; Roshan Perera; Shengxi Jin; Tran-Chin Yang; Thomas A Bryson; Masanori Sono; John H Dawson; Brian M Hoffman
Journal:  J Am Chem Soc       Date:  2005-02-09       Impact factor: 15.419

5.  Characteristics of a cytochrome P-450-dependent fatty acid omega-2 hydroxylase from bacillus megaterium.

Authors:  R S Matson; R S Hare; A J Fulco
Journal:  Biochim Biophys Acta       Date:  1977-06-22

6.  Investigation of the proton-assisted pathway to formation of the catalytically active, ferryl species of P450s by molecular dynamics studies of P450eryF.

Authors:  D L Harris; G H Loew
Journal:  J Am Chem Soc       Date:  1996-07-10       Impact factor: 15.419

7.  Rational evolution of a medium chain-specific cytochrome P-450 BM-3 variant.

Authors:  Q S Li; U Schwaneberg; M Fischer; J Schmitt; J Pleiss; S Lutz-Wahl; R D Schmid
Journal:  Biochim Biophys Acta       Date:  2001-02-09

Review 8.  Cytochrome P450 enzymes in the generation of commercial products.

Authors:  F Peter Guengerich
Journal:  Nat Rev Drug Discov       Date:  2002-05       Impact factor: 84.694

9.  Construction and assessment of models of CYP2E1: predictions of metabolism from docking, molecular dynamics, and density functional theoretical calculations.

Authors:  Jin-Young Park; Dan Harris
Journal:  J Med Chem       Date:  2003-04-24       Impact factor: 7.446

10.  Laboratory evolution of a soluble, self-sufficient, highly active alkane hydroxylase.

Authors:  Anton Glieder; Edgardo T Farinas; Frances H Arnold
Journal:  Nat Biotechnol       Date:  2002-10-07       Impact factor: 54.908

View more
  5 in total

1.  Biochemical and structural characterization of CYP124: a methyl-branched lipid omega-hydroxylase from Mycobacterium tuberculosis.

Authors:  Jonathan B Johnston; Petrea M Kells; Larissa M Podust; Paul R Ortiz de Montellano
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-20       Impact factor: 11.205

2.  QM/MM Simulation on P450 BM3 Enzyme Catalysis Mechanism.

Authors:  Li Tian; Richard A Friesner
Journal:  J Chem Theory Comput       Date:  2009       Impact factor: 6.006

3.  The role of active-site Phe87 in modulating the organic co-solvent tolerance of cytochrome P450 BM3 monooxygenase.

Authors:  Jochen Kuper; Kang Lan Tee; Matthias Wilmanns; Danilo Roccatano; Ulrich Schwaneberg; Tuck Seng Wong
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-08-29

4.  Integrated analysis of cytochrome P450 gene superfamily in the red flour beetle, Tribolium castaneum.

Authors:  Fang Zhu; Timothy W Moural; Kapil Shah; Subba Reddy Palli
Journal:  BMC Genomics       Date:  2013-03-14       Impact factor: 3.969

5.  Understanding a substrate's product regioselectivity in a family of enzymes: a case study of acetaminophen binding in cytochrome P450s.

Authors:  Yue Yang; Sergio E Wong; Felice C Lightstone
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.